BAM vs BRK-B

The Advanced Deterministic Scorecard reveals a weak Piotroski F-Score of 3/9, indicating poor financial health, which raises concerns despite strong profitability and growth metrics. The absence of an Altman Z-Score prevents a full distress risk assessment, but the low Piotroski score suggests operational or balance sheet weaknesses. While the company exhibits robust ROE (22.57%), high margins, and strong earnings growth (34.3% YoY), these are offset by an elevated valuation (P/E 33.29, P/B 9.77) and a concerning 109.19% payout ratio that threatens dividend sustainability. Price performance has weakened recently, with a 1Y return of -9.3%, and insider sentiment is neutral, offering no catalysts.

The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.